XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
6 Months Ended
Jun. 30, 2019
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

15.          RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

On February 14, 2020, the Company filed a Form 8-K disclosing that the Audit & Finance Committee of the Company’s Board of Directors determined, based on the recommendation of management, that the Company’s consolidated financial statements which were included in its annual report on Form 10-K for the year ended December 31, 2018, quarterly reports on Forms 10-Q for the quarters ended March 31, 2018, June 30, 2018, and September 30, 2018 and quarterly reports on Forms 10-Q for the quarters ended March 31, 2019, June 30, 2019, and September 30, 2019 and related financial information should no longer be relied upon, and determined that the consolidated financial statements will be restated. The errors were uncovered as part of the preparation of the Company’s consolidated financial statements for the fiscal year ended December 31, 2019.

 

As a result, the Company restated the 2018 consolidated financial statements, which is referred to as the  “Restatement.” The Restatement corrects errors which are discussed in detail within this footnote.

 

The errors primarily related to the timing of recognition of revenue from contracts with customers.

 

Restatement

 

The following is a discussion of the restatement adjustments that were made to the Company’s previously issued June 30, 2019 and June 30, 2018 consolidated financial statements.

 

(a) Revenue recognition

 

The Company recognizes revenues and profits for contracts with customers using the cost-to-cost percentage of completion method of accounting. Historically, for long-term programs, the Company applied the cost-to-cost percentage of completion method at the program level, that is, for the entire duration of expected production activity on a particular program. The Company estimated its revenue recognition utilizing the life of the program to both measure progress and estimate profit margin. Under this approach, the Company estimated the total expected customer purchases over the life of the program, which included unexercised and non-binding customer purchase options, which resulted in the recognition of $106.7 million and $100.9 million of misstated contract assets, contract liabilities and loss reserves for the three months ended June 30, 2019 and year ended December 31, 2018, respectively.

 

The Company has now concluded that its life of the program accounting was not an appropriate application of ASC Topic 606. Under ASC Topic 606, the performance obligation is the appropriate unit of accounting. The Company identifies performance obligations to customers once a contract is established in accordance with ASC Topic 606. For the Company, the contract under ASC Topic 606 is typically established upon execution of a purchase order either in accordance with a long-term customer agreement or on a standalone basis. The transaction price is also determined at the contract level and excludes amounts related to unexercised customer options. Similarly, the Company’s cost-to-cost input method to measure progress must consider only the costs incurred relative to the total expected costs of satisfying the performance obligations identified in the contract, exclusive of unexercised customer options.

 

To correct these errors, the related revenue was reversed in the period in which the accounting errors took place and recognized in subsequent periods as control of the goods or services in the contract passed to the customer over time based on a cost-to-cost input method measure of progress. Additionally, certain adjustments to contract assets and contract liabilities were made to the consolidated balance sheet at the end of the period in which the accounting errors occurred.

 

(b) Other

 

The Company corrected other immaterial misstatements relating to previously unrecorded audit adjustments.

 

(c) Income taxes

 

The Company has recorded tax adjustments related to the impact of the Restatement.

 

Impact on Consolidated Statements of Operations

 

The effect of the Restatement described above on the accompanying consolidated statements of operations for the three and six months ended June 30, 2019 is as follows:

 

   Three Months Ended June 30, 2019 
   As Previously
Reported
   Revenue
Recognition
   Other   Income
Taxes
   As Restated 
Revenue  $23,158,251   $(3,056,538)  $   $   $20,101,713 
Cost of sales   18,202,069    (175,696)   (168,303)       17,858,070 
Gross profit   4,956,182    (2,880,842)   168,303        2,243,643 
Selling, general and administrative expenses   2,709,313        (161,551)       2,547,762 
Income (loss) from operations   2,246,869    (2,880,842)   329,854        (304,119)
Interest expense   575,412                575,412 
Income (loss) before provision for (benefit from) income taxes   1,671,457    (2,880,842)   329,854        (879,531)
Provision for (benefit from) income taxes   (1,039,000)           1,040,636    1,636 
Net income (loss)  $2,710,457   $(2,880,842)  $329,854   $(1,040,636)  $(881,167)
                          
Income (loss) per common share – basic  $0.23                  $(0.07)
Income  (loss) per common share – diluted  $0.23                  $(0.07)
                          
Shares used in computing earnings per common share:                         
Basic   11,607,415                   11,817,713 
Diluted   11,644,768                   11,817,713 

 

   Six Months Ended June 30, 2019 
   As Previously
Reported
   Revenue
Recognition
   Other   Income
Taxes
   As Restated 
Revenue  $48,741,782   $(6,651,686)  $   $   $42,090,096 
Cost of sales   38,369,790    (838,449)   (168,303)       37,363,038 
Gross profit   10,371,992    (5,813,237)   168,303        4,727,058 
Selling, general and administrative expenses   5,515,756        (62,309)       5,453,447 
Income (loss) from operations   4,856,236    (5,813,237)   230,612        (726,389)
Interest expense   1,086,181                1,086,181 
Income (loss) before provision for (benefit from) income taxes   3,770,055    (5,813,237)   230,612        (1,812,570)
Provision for (benefit from) income taxes   (599,000)           602,313    3,313 
Net income (loss)  $4,369,055   $(5,813,237)  $230,612   $(602,313)  $(1,815,883)
                          
Income (loss) per common share – basic  $0.37                  $(0.15)
Income (loss) per common share – diluted  $0.37                  $(0.15)
                          
Shares used in computing earnings per common share:                         
Basic   11,710,357                   11,776,107 
Diluted   11,747,711                   11,776,107 

 

Impact on Consolidated Statements of Operations

 

The effect of the Restatement described above on the accompanying consolidated statements of operations for the three and six months ended June 30, 2018 is as follows:

  

   Three Months Ended June 30, 2018 
   As Previously Reported   Revenue Recognition   Other   Income Taxes   As Restated 
Revenue  $20,261,239   $(3,085,560)  $   $   $17,175,679 
Cost of sales   15,676,421    452,682            16,129,103 
Gross profit   4,584,818    (3,538,242)           1,046,576 
Selling, general and administrative expenses   2,557,759        (45,086)       2,512,673 
Income (loss) from operations   2,027,059    (3,538,242)   45,086        (1,466,097)
Interest expense   416,834                416,834 
Income (loss) before provision for (benefit from) income taxes   1,610,225    (3,538,242)   45,086        (1,882,931)
Provision for (benefit from) income taxes   353,000            (351,825)   1,175 
Net income (loss)  1,257,225   (3,538,242)  45,086   351,825   (1,884,106)
Other comprehensive income net of tax – Change                          
in unrealized loss on interest rate swap   20,600                20,600 
Comprehensive income (loss)  $1,277,825   $(3,538,242)  $45,086   $351,825   $(1,863.506)
                          
Income (loss) per common share – basic  $0.14                  $(0.21)
Income (loss) per common share – diluted  $0.14                  $(0.21)
                          
Shares used in computing earnings per common share:                         
Basic   8,938,331                   8,938,331 
Diluted   8,980,155                   8,938,331 

 

   Six Months Ended June 30, 2018 
   As Previously Reported   Revenue Recognition   Other   Income Taxes   As Restated 
Revenue  $38,452,862   $(6,287,232)  $   $   $32,165,630 
Cost of sales   29,818,176    480,544    (280,143)       30,018,577 
Gross profit   8,634,686    (6,767,776)   280,143        2,147,053 
Selling, general and administrative expenses   4,607,599                4,607,599 
Income (loss) from operations   4,027,087    (6,767,776)   280,143        (2,460,546)
Interest expense   864,097                864,097 
Income (loss) before provision for (benefit from) income taxes   3,162,990    (6,767,776)   280,143        (3,324,643)
Provision for (benefit from) income taxes   649,000            (646,630)   2,370 
Net income (loss)  2,513,990   (6,767,776)  280,143   646,630   (3,327,013)
Other comprehensive income net of tax – Change                          
in unrealized loss on interest rate swap   14,800                14,800 
Comprehensive income (loss)  $2,528,790   $(6,767,776)  $280,143   $646,630   $(3,312,213)
                          
Income (loss) per common share – basic  $0.28                  $(0.37)
Income (loss) per common share – diluted  $0.28                  $(0.37)
                          
Shares used in computing earnings per common share:                         
Basic   8,913,394                   8,913,394 
Diluted   8,953,321                   8,913,394 

 

 

Impact on Consolidated Balance Sheets

 

The effect of the Restatement described above on the accompanying consolidated balance sheets as of June 30, 2019 and December 31, 2018 is as follows:

 

   As of June 30, 2019 
   As Previously
Reported
   Revenue
Recognition
   Other   Income
Taxes
   As Restated 
ASSETS                    
Current Assets:                         
Cash  $752,607   $   $   $   $752,607 
Restricted cash   2,000,000                2,000,000 
Accounts receivable, net   8,399,920        161,551        8,561,471 
Contract assets   120,254,379    (104,091,748)           16,162,631 
Inventory   11,956,006        (182,083)       11,773,923 
Refundable income taxes   435,000        (47,035)   273,249    661,214 
Prepaid expenses and other current assets   1,118,620                1,118,620 
Total Current Assets   144,916,532    (104,091,748)   (67,567)   273,249    41,030,466 
                          
Operating lease right-of-use assets   4,626,916                4,626,916 
Property and equipment, net   3,362,084                3,362,084 
Refundable income taxes               434,903    434,903 
Deferred income taxes   488,319        435,000    (923,319)    
Other assets   230,258                230,258 
Total Assets  $153,624,109   $(104,091,748)  $367,433   $(215,167)  $49,684,627 
                          
Liabilities and Shareholders’ Equity (Deficit)                         
Current Liabilities:                         
Accounts payable  $11,540,234   $   $   $   $11,540,234 
Accrued expenses   927,672                927,672 
Contract liabilities   3,272,217    (38,340)           3,233,877 
Loss reserve   216,606    2,615,485            2,832,091 
Current portion of long-term debt   2,507,060                2,507,060 
Operating lease liabilities   1,637,869                1,637,869 
Income taxes payable   453,828        387,965    (724,488)   117,305 
Total Current Liabilities   20,555,486    2,577,145    387,965    (724,488)   22,796,108 
                          
Line of credit   25,738,685                25,738,685 
Long-term operating lease liabilities   3,464,146                3,464,146 
Long-term debt, net of current portion   2,981,869                2,981,869 
Deferred income taxes   2,638,415            (2,638,415)    
Total Liabilities   55,378,601    2,577,145    387,965    (3,362,903)   54,980,808 
                          
Shareholders’ Equity (Deficit):                         
Common stock   11,820                11,820 
Additional paid-in capital   71,104,418                71,104,418 
Retained earnings (accumulated deficit)   27,129,270    (106,668,893)   (20,532)   3,147,736    (76,412,419)
Total Shareholders’ Equity (Deficit)   98,245,508    (106,668,893)   (20,532)   3,147,736    (5,296,181)
                          
Total Liabilities and Shareholders’ Equity (Deficit)  $153,624,109   $(104,091,748)  $367,433   $(215,167)  $49,684,627 

 

   As of December 31, 2018 
   As Previously
Reported
   Revenue
Recognition
   Other   Income
Taxes
   As
Restated
 
ASSETS                    
Current Assets:                         
Cash  $4,128,142   $   $   $   $4,128,142 
Restricted cash   2,000,000                2,000,000 
Accounts receivable, net   8,623,329        99,242        8,722,571 
Contract assets   113,333,491    (95,744,625)           17,588,866 
Inventory   9,711,997        (350,386)       9,361,611 
Refundable income taxes   435,000            (97)   434,903 
Prepaid expenses and other current assets   1,972,630                1,972,630 
Total Current Assets   140,204,589    (95,744,625)   (251,144)   (97)   44,208,723 
                          

Property and equipment, net

   2,545,192                2,545,192 
Refundable income taxes   435,000            (97)   434,903 
Deferred income taxes   279,318            (279,318)    
Other assets   249,575                249,575 
Total Assets  $143,713,674   $(95,744,625)  $(251,144)  $(279,512)  $47,438,393 
                          

Liabilities and Shareholders’ Equity (Deficit)

                         
Current Liabilities:                         
Accounts payable  $9,902,481   $   $   $   $9,902,481 
Accrued expenses   1,558,160                1,558,160 
Contract liabilities   3,588,500    1,664,079            5,252,579 
Loss reserve   216,606    3,446,952            3,663,558 

Current portion of long-term debt

   2,434,981                2,434,981 

Income taxes payable

   115,000            (1,008)   113,992 

Total Current Liabilities

   17,815,728    5,111,031        (1,008)   22,925,751 
                          
Line of credit   24,038,685                24,038,685 

Long-term debt, net of current portion

   3,876,238                3,876,238 
Deferred income taxes   4,028,553            (4,028,553)    
Other liabilities   531,124                531,124 
Total Liabilities    50,290,328    5,111,031        (4,029,561)   51,371,798 
                          
Shareholders’ Equity (Deficit):                         
Common stock   11,718                11,718 
Additional paid-in capital   70,651,413                70,651,413 
Retained earnings (accumulated deficit)   22,760,215    (100,855,656)   (251,144)   3,750,049    (74,596,536)
Total Shareholders’ Equity (Deficit)   93,423,346    (100,855,656)   (251,144)   3,750,049    (3,933,405)
                          
Total Liabilities and Shareholders’ Equity (Deficit)  $143,713,674   $(95,744,625)  $(251,144)  $(279,512)  $47,438,393 

 

 

Cumulative Effect of Prior Period Adjustments

 

The following table presents the impact of the Restatement on the Company’s shareholders’ equity (deficit) as of January 1, 2018:

                     
   Common
Stock
   Additional
Paid-in
Capital
   Retained
Earnings
(Accumulated
Deficit)
   Accumulated
Other
Comprehensive
Loss
  

Total
Shareholders’
Equity (Deficit)

 
Balance, January 1, 2018                    
(As previously reported)  $8,864   $53,770,617   $20,548,652   $(14,800)  $74,313,333 
Adjustments:                         
Revenue recognition           (86,621,280)       (86,621,280)
Other           (280,143)       (280,143)
Income taxes           (697,012)       (697,012)
                          
Cumulative restatement adjustments           (87,598,435)       (87,598,435)
Balance, January 1, 2018                         
(As Restated)  $8,864   $53,770,617   $(67,049,783)  $(14,800)  $(13,285,102)

 

 

Impact on Consolidated Statements of Cash Flows

 

The effect of the Restatement described above on the accompanying consolidated statements of cash flows for the six months ended June 30, 2019 and 2018 is as follows:

 

   Six Months Ended June 30, 2019 
   As Previously Reported   Restatement Adjustments   As Restated 
Cash flows from operating activities:               
Net income (loss)  $4,369,055   $(6,184,938)  $(1,815,883)
Adjustments to reconcile net income (loss) to net cash used in operating activities:               
Depreciation and amortization   483,982        483,982 
Amortization of debt issuance cost   44,317    16,929    61,246 
Cash expended in excess of rent expense   (56,024)       (56,024)
Stock-based compensation   540,354        540,354 
Common stock issued as employee compensation   32,324        32,324 
Bad debt expense       (62,309)   (62,309)
Deferred income taxes   (1,599,139)   1,599,139     
Changes in operating assets and liabilities:               
Decrease in accounts receivable   223,409        223,409 
(Increase) decrease in contract assets   (6,920,888)   8,347,122    1,426,234 
Increase in inventory   (2,244,009)   (168,303)   (2,412,312)
(Increase) decrease in refundable income taxes   435,000    (661,311)   (226,311)
Decrease in prepaid expenses and other current assets   645,522    (17,053)   628,469 
Increase in accounts payable and accrued expenses   1,007,265        1,007,265 
Decrease in contract liabilities   (694,408)   (1,702,294)   (2,396,702)
Decrease in loss reserve       (831,467)   (831,467)
Increase in income taxes payable   338,828    (335,515)   3,313 
Net cash used in operating activities   (3,394,412)       (3,394,412)
Cash flows from investing activities:               
Purchase of property and equipment   (314,462)       (314,462)
Net cash used in investing activities   (314,462)       (314,462)
Cash flows from financing activities:               
Payments of long-term debt   (1,222,090)       (1,222,090)
Proceeds from line of credit   2,000,000        2,000,000 
Payments of line of credit   (300,000)       (300,000)
Stock offering costs paid   (119,571)       (119,571)
Debt issuance costs   (25,000)       (25,000)
Net cash provided by financing activities   333,339        333,339 
Net decrease in cash and restricted cash   (3,375,535)       (3,375,535)
Cash and restricted cash at beginning of period   6,128,142        6,128,142 
Cash and restricted cash at end of period  $2,752,607   $   $2,752,607 
                
Supplemental disclosures of cash flow information:               
Cash paid during the period for interest  $1,329,678   $   $1,329,678 
Cash paid during the period for income taxes  $141,702   $   $141,702 
Supplemental schedule of noncash investing and financing activities:               
Equipment acquired under financing lease  $399,800   $   $399,800 

 

 

   Six Months Ended June 30, 2018 
   As Previously Reported   Restatement Adjustments   As Restated 
Cash flows from operating activities:               
Net income (loss)  $2,513,990   $(5,841,003)  $(3,327,013)
Adjustments to reconcile net income (loss) to net cash used in operating activities:               
Depreciation and amortization   333,276        333,276 
Amortization of debt issuance cost   42,785        42,785 
Cash expended in excess of rent expense   (35,384)       (35,384)
Stock-based compensation   459,716        459,716 
Common stock issued as employee compensation   45,913        45,913 
Adjustment for maturity of interest rate swap    20,600    (5,800)   14,800 
Bad debt expense            
Deferred income taxes   755,500    (755,500)    
Changes in operating assets and liabilities:               
Increase in accounts receivable   (10,724)       (10,724)
(Increase) decrease in contract assets   (4,021,904)   6,638,916    2,617,012 
Increase in inventory   (125,526)       (125,526)
Increase in prepaid expenses, other current assets and refundable income taxes   (158,636)   (130)   (158,766)
Decrease in accounts payable and accrued expenses   (3,619,073)   (280,143)   (3,899,216)
Increase in contract liabilities   292,317    (2,658)   289,659 
Increase in loss reserve   44,933    131,518    176,451 
Decrease in other liabilities   (10,976)   5,800    (5,176)
Decrease in income taxes payable   (109,327)   109,000    (327)
Net cash used in operating activities   (3,582,520)       (3,582,520)
Cash flows from investing activities:               
Purchase of property and equipment   (369,738)       (369,738)
Net cash used in investing activities   (369,738)       (369,738)
Cash flows from financing activities:               
Payments of long-term debt   (946,521)       (946,521)
Proceeds from line of credit   4,500,000        4,500,000 
Net cash used in financing activities   3,553,479        3,553,479 
Net decrease in cash   (398,779)       (398,779)
Cash at beginning of period   1,430,877        1,430,877 
Cash at end of period  $1,032,098   $   $1,032,098 
                
Supplemental disclosures of cash flow information:               
Cash paid during the period for interest  $1,047,457   $   $1,047,457 
Supplemental schedule of noncash investing and financing activities:               
Equipment acquired under financing lease  $497,602   $   $497,602